Matinas BioPharma Holdings, Inc. - COM (MTNB)

Historical Portfolio Holders from Q1 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
38.9M
Holdings value Q2 2024
$6.15M
Value change Q2 2024
+$1.91M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
48
Number of buys Q2 2024
0
Number of sells Q2 2024
-20
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 775K $72K -$958K $0.09 1
2024 Q2 38.9M $6.15M +$1.91M $0.16 48
2024 Q1 25.4M $6.91M -$32.7K $0.27 41
2023 Q4 25.9M $5.6M +$75K $0.22 51
2023 Q3 25.9M $3.37M -$135K $0.13 47
2023 Q2 25.8M $9.3M -$280K $0.36 50
2023 Q1 26.5M $12.6M -$332K $0.47 50
2022 Q4 27.2M $13.6M -$255K $0.50 55
2022 Q3 27.9M $18M +$441K $0.64 48
2022 Q2 27.2M $21.5M +$1.56M $0.79 46
2022 Q1 25.2M $20.3M -$1.94M $0.80 51
2021 Q4 27.1M $27.3M +$1.01M $1.01 61
2021 Q3 25.7M $33.5M -$8.49M $1.30 66
2021 Q2 37.7M $29.2M -$4.04M $0.77 61
2021 Q1 39.7M $41.7M -$4.93M $1.05 77
2020 Q4 41.9M $57M -$4.64M $1.36 68
2020 Q3 45.4M $34.8M -$1.56M $0.77 59
2020 Q2 47.4M $36.7M -$4.53M $0.77 63
2020 Q1 53.4M $32M +$13.7M $0.60 62
2019 Q4 29.7M $67.4M +$10.1M $2.27 61
2019 Q3 26.3M $16.6M -$5.75M $0.63 35
2019 Q2 32.3M $27.7M -$5.28M $0.86 46
2019 Q1 37.7M $41.1M +$27.2M $1.09 52
2018 Q4 13.8M $8.24M +$3.55M $0.60 32
2018 Q3 7.17M $6.6M -$807K $0.92 30
2018 Q2 8.43M $3.66M -$1.85M $0.43 36
2018 Q1 11M $8.41M +$21.2K $0.77 43
2017 Q4 11.2M $13M -$321K $1.16 49
2017 Q3 11.4M $15.1M +$1.12M $1.32 47
2017 Q2 10.6M $18M +$13.4M $1.69 44
2017 Q1 2.51M $7.01M +$7.01M $2.77 19
2016 Q3 182K $291K -$3.2K $1.60 1
2016 Q2 184K $145K $0 $0.79 1
2016 Q1 184K $130K -$54.8K $0.71 1
2015 Q4 243K $207K +$131K $0.85 2
2015 Q3 89.8K $74K +$49.4K $0.82 1
2015 Q2 29.8K $30K $0 $1.01 1
2015 Q1 29.8K $16K +$16K $0.54 1